In this episode, Dr. Kate Dee and Dr. Randy Lindstrom discuss weight loss medications, particularly focusing on the benefits and differences between Semaglutide (Ozempic/Wegovy) and Tirzepatide (Manjaro/ZepBound). They explain the scientific mechanisms, potential side effects, and legal issues surrounding these treatments. Both doctors share their personal experiences using these drugs and highlight the importance of medical guidance when undergoing such treatments. They also introduce their new weight loss program, GlowFit, and its structured approach to helping patients achieve their weight loss goals safely and effectively.

Check out the Medspa Mayhem website for

• More about Dr. Dee

• Upcoming appearances

• Links to buy the book on Bookshop, B&N, Amazon

• Press and Podcast info

Glow Medispa in Seattle, WA

Purchase Medspa Mayhem on Amazon

Find out more about GlowFit Tirzepatide program

Takeaways

• Tirzepatide is a weight loss medication that decreases appetite and slows emptying of the stomach

• Medical management is crucial for safe and effective weight loss.

• Personal experiences with Tirzepatide show significant weight loss with few side effects.

• The Glowfit program aims to provide comprehensive support for weight loss.

• Education about the medication and its effects is essential for users.

• Tirzepatide has a lower side effect profile compared to semaglutide.

• The future of weight loss medications is promising with ongoing research.

• Maintaining muscle mass is important during weight loss.

• The program is designed to cater to a wide range of weight loss goals.

Chapters

00:00 Food Chatter and Its Impact

01:24 Meet Dr. Randy Lindstrom

02:12 Excitement About Tirzapatide

04:04 Understanding Ozempic and Its Side Effects

08:37 All about Tirzapatide

13:01 Launching the Glow Fit Program

17:06 Sourcing and Legality of Weight Loss Drugs

23:27 Personal Experiences with Terzapatide

32:41 Conclusion and Future Plans